Ephrin ligands prime pancreatic endoderm cells to accelerate endocrine cluster formation, resolving slow clustering in stem cell differentiation protocols.
Engineering beta cells to reduce Cavβ3 expression improves glucose tolerance and insulin secretion without increasing hypoglycemia risk.
A polyhormonal intermediate protocol generates functional stem cell-derived alpha cells using PKC activators.